Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 20%. Looking ahead, revenue is forecast to grow 3.2% p.a. on average during the next 3 years, ...
Deriving the right royalty rate for new pharmaceuticals and ... Duration of Profits. How long will the profits continue? Consider patent life, technological obsolescence and consumer reaction.
November 13, 2024 • The youngest ever winner of the Van Cliburn Piano Competition makes our trusty upright piano sound like a 9-foot grand in music by Liszt and Tchaikovsky.